Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials (Q33896347)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Grandjean EM

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Berthet P

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ruffmann R

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Leuenberger P

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

209-221

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment cost of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GSH rescue by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative Stress in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapies for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of randomized controlled trials. A concern for standards;

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988479-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(00)88479-9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33896347&oldid=1612181527"